Saïdal, Boehringer Ingelheim to produce pulmonary fibrosis drug in Algeria

ALGIERS - The state-owned pharmaceutical group Saïdal signed a cooperation agreement Monday in Algiers with Boehringer Ingelheim, a German pioneer in biopharmaceutical research and development, to manufacture and produce an innovative treatment for pulmonary fibrosis in Algeria.